Ares Acquisition Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David B. Kaplan
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 245 Park Avenue New York City NY United States of America 10167
- IPO Date
- Mar 25, 2021
- CIK
- 0001829432
- Similar Companies
- Business
- Ares Acquisition Corporation (NYSE: AAC) is a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company has not yet completed its initial business combination and focuses on target companies in the industrials, manufacturing, or business services sectors, particularly those with enterprise values between $1 billion and $5 billion. Its securities offerings include 34,500,000 units sold in its initial public offering at $10.00 per unit, comprising one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable for one share of Class A common stock at $11.50; the company does not have operations of its own and holds investment proceeds in a trust account for the benefit of public stockholders. Ares Acquisition Corporation was founded in 2020 and is headquartered in New York, New York, with operations managed through its sponsor, Ares Acquisition Holdings LP, an affiliate of Ares Management Corporation. As of late 2025, the company continues to seek a suitable business combination target, with no publicly announced recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts in the past 1-2 years.
Ares Acquisition Corporation III Announces Pricing of Upsized $345 Million Initial Public Offering
AAC&U Releases New Report on Advancing Public Trust in Higher Education
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®
GenSight Biologics Reaches Agreement with ANSM for Opening of LUMEVOQ® Named Early Access Program (AAC) in France
Why X-Energy Partner Ares Acquisition Stock Popped 9% Today
X-energy and Ares Acquisition Corporation Mutually Agree to Terminate Business Combination Agreement
U.S. Department of Energy Signs Cooperative Agreement to Further Develop X-energy's Microreactor for Commercial Applications
X-Energy Participates in SPAC Insider Podcast
X-Energy Announces Participation in IPO Edge Fireside Chat
Ares Acquisition Corporation and X-Energy Reactor Company, LLC Announce Effectiveness of Registration Statement and October 31, 2023 Extraordinary General Meeting to Approve Business Combination
Department of Defense Expands X-energy Contract for Mobile Microreactor Prototype
Department of Defense Expands X-energy Contract for Mobile Microreactor Prototype
X-energy and Ares Acquisition Corporation Announce Additional Committed Capital and Attractive Strategic Updates to Business Combination
Ares Acquisition Corporation Announces Successful Second Extension and Redemption Results
Ares Acquisition Corporation Announces Continuation of Monthly Contributions to Trust Account in Connection With Proposed Second Extension
Energy Northwest and X-energy Sign Joint Development Agreement for Xe-100 Advanced Small Modular Reactor Project
X-Energy Reactor and Ares Acquisition Corp. cut $300 million off merger price
Dow's Seadrift, Texas location selected for X-energy advanced SMR nuclear project to deliver safe, reliable, zero carbon emissions power and steam production
These Are the Top 10 Holdings of Robert Lynch
Dow and X-energy Advance Efforts to Deploy First Advanced Small Modular Nuclear Reactor at Industrial Site Under DOE's Advanced Reactor Demonstration Program